10-Q Filing

ABBVIE INC. CIK: 1551152 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001551152-20-000023`
Period End Date	20200630
Filing Date	20200804
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	abbv-20200630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 76 Cash Flow Statement 83 Stockholders Equity 36 Comprehensive Income 60

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.02B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.92B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.79B	shares	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	24.14M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$23.00M	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	302.67M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.43B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$8.35B	USD	Point-in-time
Inventories	`InventoryNet`	$4.06B	USD	Point-in-time
Inventories	`InventoryNet`	$1.81B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$2.80B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$2.35B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.26B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$49.52B	USD	Point-in-time
Investments	`LongTermInvestments`	$93.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$225.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.96B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.91B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$76.46B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$18.65B	USD	Point-in-time
Goodwill	`Goodwill`	$15.60B	USD	Point-in-time
Goodwill	`Goodwill`	$42.67B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.01B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.29B	USD	Point-in-time
Total assets	`Assets`	$149.53B	USD	Point-in-time
Total assets	`Assets`	$89.11B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$64.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	-	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.75B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.31B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$11.83B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$19.27B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.59B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.65B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$82.06B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$62.98B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.79B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.13B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$23.31B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.60B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,788,423,670 shares issued as of June 30, 2020 and 1,781,582,608 as of December 31, 2019	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,788,423,670 shares issued as of June 30, 2020 and 1,781,582,608 as of December 31, 2019	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 24,140,541 shares as of June 30, 2020 and 302,671,146 as of December 31, 2019	`TreasuryStockValue`	$24.50B	USD	Point-in-time
Common stock held in treasury, at cost, 24,140,541 shares as of June 30, 2020 and 302,671,146 as of December 31, 2019	`TreasuryStockValue`	$1.96B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$16.95B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$15.19B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.13B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.72B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.44B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.60B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-8.17B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$14.71B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$24.00M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.83B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.42B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.57B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$89.11B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$149.53B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$19.04B	USD	2 Qtrs
Net revenues	`Revenues`	$16.08B	USD	2 Qtrs
Net revenues	`Revenues`	$10.43B	USD	1 Quarter
Net revenues	`Revenues`	$8.26B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$1.82B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$3.51B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$3.71B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.65B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.33B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.53B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.65B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.22B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.96B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.58B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.58B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.29B	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$853.00M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$91.00M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$853.00M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$246.00M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$14.69B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$4.86B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$9.67B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$9.67B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$4.36B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$3.40B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$6.41B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$752.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-634.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.04B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-309.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-614.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-12.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-6.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-34.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-29.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.41B	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.28B	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-802.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-874.00M	USD	2 Qtrs
Earnings (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.40B	USD	2 Qtrs
Earnings (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$807.00M	USD	1 Quarter
Earnings (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.35B	USD	2 Qtrs
Earnings (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-693.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$46.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$154.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$66.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$134.00M	USD	2 Qtrs
Net earnings (loss)	`ProfitLoss`	$3.20B	USD	2 Qtrs
Net earnings (loss)	`ProfitLoss`	$2.27B	USD	2 Qtrs
Net earnings (loss)	`ProfitLoss`	$-739.00M	USD	1 Quarter
Net earnings (loss)	`ProfitLoss`	$741.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	2 Qtrs
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$2.27B	USD	2 Qtrs
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$3.20B	USD	2 Qtrs
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$-738.00M	USD	1 Quarter
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$741.00M	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.15	USD	2 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$1.44	USD	2 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$-0.46	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.43	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.49	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$2.14	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$-0.46	USD	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.65B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.48B	shares	2 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.48B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.56B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.48B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.48B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.65B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.57B	shares	2 Qtrs

Cash Flow Statement 83 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$3.20B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$2.27B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$-739.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$741.00M	USD	1 Quarter
Depreciation	`Depreciation`	$149.00M	USD	1 Quarter
Depreciation	`Depreciation`	$114.00M	USD	1 Quarter
Depreciation	`Depreciation`	$232.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$264.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.40B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.85B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$773.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$388.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$72.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-257.00M	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.47B	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$881.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$276.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$455.00M	USD	2 Qtrs
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$943.00M	USD	2 Qtrs
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$321.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$10.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-434.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$543.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$304.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$288.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-240.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$270.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$466.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-366.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$204.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-820.00M	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.49B	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.90B	USD	2 Qtrs
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$38.14B	USD	2 Qtrs
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$192.00M	USD	2 Qtrs
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$440.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$302.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$235.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$558.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$32.00M	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.07B	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.43B	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.45B	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-35.78B	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-167.00M	USD	2 Qtrs
Net change in commercial paper borrowings	`ProceedsFromRepaymentsOfCommercialPaper`	-	USD	2 Qtrs
Net change in commercial paper borrowings	`ProceedsFromRepaymentsOfCommercialPaper`	$-393.00M	USD	2 Qtrs
Repayments of other short-term borrowings	`RepaymentsOfOtherShortTermDebt`	-	USD	2 Qtrs
Repayments of other short-term borrowings	`RepaymentsOfOtherShortTermDebt`	$3.00B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.00B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.00M	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$3.76B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`PaymentOfFinancingAndStockIssuanceCosts`	$171.00M	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`PaymentOfFinancingAndStockIssuanceCosts`	$20.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$3.52B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$3.18B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$662.00M	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$623.00M	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$77.00M	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$108.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$129.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$20.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$21.00M	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.99B	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.45B	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-38.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$9.00M	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-33.91B	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.12B	USD	2 Qtrs
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.17B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.02B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.29B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.17B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.02B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.29B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	-	USD	2 Qtrs
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	$23.98B	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.83B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.42B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.57B	USD	Point-in-time
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$2.27B	USD	2 Qtrs
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$3.20B	USD	2 Qtrs
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$-738.00M	USD	1 Quarter
Net earnings (loss) attributable to AbbVie Inc.	`NetIncomeLoss`	$741.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$262.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$161.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$25.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-11.00M	USD	2 Qtrs
Dividends declared	`DividendsCommonStockCash`	$1.59B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$2.10B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$3.86B	USD	2 Qtrs
Dividends declared	`DividendsCommonStockCash`	$3.18B	USD	2 Qtrs
Common shares and equity awards issued for acquisition of Allergan plc	`StockIssuedDuringPeriodValueAcquisitions`	$24.41B	USD	1 Quarter
Common shares and equity awards issued for acquisition of Allergan plc	`StockIssuedDuringPeriodValueAcquisitions`	$24.41B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$3.00M	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$422.00M	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$662.00M	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$19.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$88.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$314.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$559.00M	USD	2 Qtrs
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$297.00M	USD	2 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$24.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$24.00M	USD	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.83B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.42B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.57B	USD	Point-in-time

Comprehensive Income 60 line items

Line Item	Tag	Value	Unit	Period
Net earnings (loss)	`ProfitLoss`	$3.20B	USD	2 Qtrs
Net earnings (loss)	`ProfitLoss`	$2.27B	USD	2 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$4.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$6.00M	USD	2 Qtrs
Net earnings (loss)	`ProfitLoss`	$-739.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-4.00M	USD	2 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$5.00M	USD	1 Quarter
Net earnings (loss)	`ProfitLoss`	$741.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-11.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $4 for the three months and $(4) for the six months ended June 30, 2020 and $5 for the three months and $6 for the six months ended June 30, 2019	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$441.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-40.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-60.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $4 for the three months and $(4) for the six months ended June 30, 2020 and $5 for the three months and $6 for the six months ended June 30, 2019	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$71.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $4 for the three months and $(4) for the six months ended June 30, 2020 and $5 for the three months and $6 for the six months ended June 30, 2019	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$214.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$8.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $4 for the three months and $(4) for the six months ended June 30, 2020 and $5 for the three months and $6 for the six months ended June 30, 2019	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-32.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-6.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-27.00M	USD	2 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months and $(40) for the six months ended June 30, 2020 and $(11) for the three months and $8 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-37.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months and $(40) for the six months ended June 30, 2020 and $(11) for the three months and $8 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-141.00M	USD	2 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months and $(40) for the six months ended June 30, 2020 and $(11) for the three months and $8 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$28.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-12.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months and $(40) for the six months ended June 30, 2020 and $(11) for the three months and $8 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-213.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-12.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $12 for the three months and $27 for the six months ended June 30, 2020 and $6 for the three months and $12 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-20.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $12 for the three months and $27 for the six months ended June 30, 2020 and $6 for the three months and $12 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-43.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $12 for the three months and $27 for the six months ended June 30, 2020 and $6 for the three months and $12 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-99.00M	USD	2 Qtrs
Marketable security activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	1 Quarter
Marketable security activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $12 for the three months and $27 for the six months ended June 30, 2020 and $6 for the three months and $12 for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-45.00M	USD	2 Qtrs
Marketable security activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	1 Quarter
Marketable security activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-4.00M	USD	2 Qtrs
Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the six months ended June 30, 2020 and $ for the three months and $ for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-2.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-9.00M	USD	2 Qtrs
Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the six months ended June 30, 2020 and $ for the three months and $ for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$11.00M	USD	2 Qtrs
Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the six months ended June 30, 2020 and $ for the three months and $ for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$4.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-2.00M	USD	1 Quarter
Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the six months ended June 30, 2020 and $ for the three months and $ for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months and $(4) for the six months ended June 30, 2020 and $(2) for the three months and $(9) for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-33.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months and $(4) for the six months ended June 30, 2020 and $(2) for the three months and $(9) for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-9.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months and $(4) for the six months ended June 30, 2020 and $(2) for the three months and $(9) for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-11.00M	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months and $(4) for the six months ended June 30, 2020 and $(2) for the three months and $(9) for the six months ended June 30, 2019	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-63.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$262.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$161.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$25.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-11.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.43B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-477.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.19B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$766.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest, net of tax	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest, net of tax	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest, net of tax	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Comprehensive loss attributable to noncontrolling interest, net of tax	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.00M	USD	2 Qtrs
Comprehensive income (loss) attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$2.43B	USD	2 Qtrs
Comprehensive income (loss) attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$766.00M	USD	1 Quarter
Comprehensive income (loss) attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$-476.00M	USD	1 Quarter
Comprehensive income (loss) attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$3.19B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.